Focus on the details and strive for excellence
Recently, Wang Yajun, Secretary General of China Pharmaceutical Equipment Industry Association, and his delegation visited Jornen for inspection and research. Jornen Chairman Yang Yijun and General Manager Jack Yang accompanied them on the inspection. The delegation visited Jornen’s latest high-speed Blister Packaging Line and its operation site, gained an in-depth understanding of its technical advantages, domestic and foreign market conditions, and the challenges and difficulties currently faced by the company, and held an exchange meeting.
As a member of the China Pharmaceutical Equipment Industry Association, Jornen integrates R&D, manufacturing, and services and provides integrated solutions and complete equipment for automated pharmaceutical production lines such as blister, cartoning, case packing, palletizing, and intelligent online detection for solid doses, oral liquids and parenteral products in the pharmaceutical industry.
Company founder Mr. Yang Yijun has been developing the Blister Machines since 1985. In 1989, he launched China’s first Platen Sealing Blister Machine. We were named as one of the “Top 10 Packaging Machinery Enterprises” in China, and the “Shanghai High-Tech Enterprise” award.
In 2000, Jornen invested in the Shanghai Industrial Base and established Shanghai Jornen. As a Shanghai high-tech enterprise and a Shanghai specialized and innovative enterprise, Jornen has always regarded R&D as the company’s core strategy, continuously increasing investment and enhancing strength. Its leading product Blister Packaging Line is distributed in over 100 countries and regions, providing high-quality professional services to thousands of pharmaceutical and biotechnology units worldwide. Its perfect technical system and efficient R&D capabilities build core competitive advantages. Jornen has a complete R&D process for new product development to ensure market research, solution design, R&D implementation, test verification, market promotion, and customer feedback, forming an efficient closed-loop operation system. Since its establishment, the company has obtained nearly 100 technology R&D patents.
At the symposium, Jornen General Manager Jack Yang introduced the company’s development history, basic profile, operating conditions, and future development strategy to the association leaders and listened carefully to all parties’ opinions and suggestions on scientific management, intelligent equipment manufacturing, big data, and artificial intelligence applications.
The association affirmed Jornen’s achievements and its role in promoting the industry’s development and hoped that Jornen would always adhere to quality first, pursue excellence, participate more in the association’s exchange activities, play a corporate role, strengthen social responsibility, and contribute to the development of China’s pharmaceutical equipment industry.
Jornen thanked the association for its continued support and help. As a company with a long history in this industry, Jornen has witnessed the development of China’s pharmaceutical equipment industry. After more than 30 years of rapid development, from the initial family workshop to today’s industrial scale and technological content, the role and contribution of the industry association are apparent to all. As a member of the industry, Jornen took this opportunity to express his gratitude to the association and said that the company would continue to increase its technological innovation in the future, inherit the essence of “paying attention to details, pursuing perfection, and striving for excellence,” adhere to the core values of the enterprise of “market-oriented and innovation-centered,” continue to enhance the company’s competitiveness and create greater value for social development with more surging innovation passion and help the high-quality development of the pharmaceutical equipment industry.
